Short Interest in PureTech Health plc (NASDAQ:PRTC) Drops By 61.5%

Posted by Linda Flegge on Apr 16th, 2025

PureTech Health plc (NASDAQ:PRTC – Get Free Report) was the target of a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 9,700 shares, a drop of 61.5% from the March 15th total of 25,200 shares. Based on an average daily trading volume, of 4,400 shares, the days-to-cover ratio is currently 2.2 days. Currently, 0.0% of the company’s shares are sold short.

Hedge Funds Weigh In On PureTech Health

A hedge fund recently bought a new stake in PureTech Health stock. Birch Hill Investment Advisors LLC purchased a new position in shares of PureTech Health plc (NASDAQ:PRTC – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 302,000 shares of the company’s stock, valued at approximately $5,575,000. Birch Hill Investment Advisors LLC owned about 1.26% of PureTech Health as of its most recent filing with the Securities and Exchange Commission (SEC). 0.04% of the stock is owned by institutional investors and hedge funds.

PureTech Health Price Performance

PRTC traded down $0.20 during trading on Wednesday, hitting $16.48. 406 shares of the company’s stock were exchanged, compared to its average volume of 5,300. PureTech Health has a 1 year low of $13.30 and a 1 year high of $32.98. The stock has a 50 day moving average price of $17.75 and a 200 day moving average price of $19.34.

PureTech Health Company Profile

(Get Free Report)

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.